- Home
- NRSN vs EQS Comparison
NRSN vs EQS Comparison
Compare NRSN & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRSN | EQS |
|---|---|---|
| Founded | 2017 | 1991 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 25.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRSN | EQS |
|---|---|---|
| Price | $0.88 | $1.74 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 489.0K | 5.0K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,377,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.11 |
| 52 Week Low | $0.81 | $0.74 |
| 52 Week High | $2.60 | $2.49 |
Technical Indicators
Market Signals| Indicator | NRSN | EQS |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 39.99 |
| Support Level | $0.86 | $1.64 |
| Resistance Level | $1.24 | $1.90 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 7.89 | 14.29 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.